Review articlePublished 6 Jul 2020
AN OVERVIEW ON DOCKING STUDIES WITH ALDOSE REDUCTASE INHIBITORS
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Molecular modeling methods have become integral part of drug discovery programs as they enable study of complex biological and chemical systems and hence design of lead molecules of therapeutic significance. Over the last few decades, it has been routinely and successfully applied in most pharmaceutical and biotech companies for a large number of applications. The activation of the key enzyme Aldose reductase in polyol pathway under hyperglycemic conditions is responsible for the development of late diabetic complications and it is an important drug target. This review provides an update on the docking strategies employed for screening various synthetic and natural aldose reductase inhibitors and provide an overview of the structural features involved in binding within the active site. The docking results reveal that several active constituents of medicinal plants exhibit remarkable aldose reductase activity and they may serve as lead for the development of novel ALRs of therapeutic significance.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Research and Technology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Zeyad Ahmmed Dahan Mohammed”
- BylineArticles whose byline prints “Sayyed Hussain Sajjansab”
- BylineArticles whose byline prints “PK Zubaidha”